Tanning and vitamin D status

Tanning and vitamin D status2018-01-17T17:03:58-05:00

Distinct Effector Cytokine Profiles of Memory and Naive Human B Cell Subsets and Implication in Multiple Sclerosis

Distinct Effector Cytokine Profiles of Memory and Naive Human B Cell Subsets and Implication in Multiple Sclerosis2018-01-17T17:03:58-05:00

Extra-renal 25-hydroxyvitamin D3-1-hydroxylase in human health and disease

Extra-renal 25-hydroxyvitamin D3-1-hydroxylase in human health and disease2018-01-17T17:03:58-05:00

Activated Human T Cells, B Cells, and Monocytes Produce Brain-derived Neurotrophic Factor In Vitro and in Inflammatory Brain Lesions: A Neuroprotective Role of Inflammation?

Activated Human T Cells, B Cells, and Monocytes Produce Brain-derived Neurotrophic Factor In Vitro and in Inflammatory Brain Lesions: A Neuroprotective Role of Inflammation?2018-01-17T17:03:58-05:00

Probiotics for the Prevention of Beta Cell Autoimmunity in Children at Genetic Risk of Type 1 Diabetes—the PRODIA Study

Probiotics for the Prevention of Beta Cell Autoimmunity in Children at Genetic Risk of Type 1 Diabetes—the PRODIA Study2018-01-17T17:03:58-05:00

Adverse events associated with dietary supplements: an observational study

Adverse events associated with dietary supplements: an observational study2018-01-17T17:03:58-05:00

Vitamin K2 ameliorates experimental autoimmune encephalomyelitis in Lewis rats

Vitamin K2 ameliorates experimental autoimmune encephalomyelitis in Lewis rats2018-01-17T17:03:58-05:00

Novel synthetic amino acid copolymers that inhibit autoantigen-specific T cell responses and suppress experimental autoimmune encephalomyelitis

Novel synthetic amino acid copolymers that inhibit autoantigen-specific T cell responses and suppress experimental autoimmune encephalomyelitis2018-01-17T17:03:58-05:00

Relation between humoral pathological changes in multiple sclerosis and response to therapeutic plasma exchange

Relation between humoral pathological changes in multiple sclerosis and response to therapeutic plasma exchange2018-01-17T17:03:58-05:00

Interferon beta-1a for brain tissue loss in patients at presentation with syndromes suggestive of multiple sclerosis: a randomised, double-blind, placebo-controlled trial

Interferon beta-1a for brain tissue loss in patients at presentation with syndromes suggestive of multiple sclerosis: a randomised, double-blind, placebo-controlled trial2018-01-17T17:03:58-05:00